T-cell receptor and major histocompatibility complex class II complex

The T-cell receptor and major histocompatibility complex class II complex refers to the structure formed when a T-cell receptor (TCR) on a CD4+ T lymphocyte binds to a peptide antigen presented by a major histocompatibility complex (MHC) class II molecule, typically found on professional antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells[5][6][7]. The TCR is a heterodimeric transmembrane receptor (usually αβ) with highly variable regions generated via V(D)J recombination, enabling immense diversity of antigen recognition[10]. MHC class II molecules bind to peptides typically 13–25 amino acids in length, derived from extracellular pathogens, and present them to helper T cells (CD4+), thus initiating and coordinating adaptive immune responses[1][5][6][8]. Upon recognition of a specific peptide-MHC II complex, the TCR, together with the CD3 complex and CD4 co-receptor, transduces activation signals into the T cell, triggering processes like cytokine release, cellular proliferation, and differentiation into effector subtypes[3][4][6][9]. This interaction is critical for immune responses against infections and tumors, but dysregulation can cause autoimmunity or immune deficiency. Disruption or modulation of this recognition step is a key therapeutic target in immunology and clinical medicine.

Other names

TCR-MHC class II complexT-cell receptor:peptide:MHC class IITCR:pMHCII

Inhibition of TCR signaling (e.g., via anti-CD3 monoclonal antibodies) Blockade of co-stimulatory signaling (e.g., CTLA-4-Ig/Abatacept) Suppression of antigen presentation (e.g., antagonistic anti-MHC class II antibodies)